By moving up 12 places in the PatientView ranking results from the survey assessing on the reputation of pharmaceutical companies that work with patient organizations, we are stepping up the progress made over the past few years. Because at Servier, we are particularly attentive to working with patients, and the organizations that represent them, during each stage of the medicine life cycle.
We placed 14th (+12 places) in the ranking for patient organizations working with us. We also moved up to the 20th spot (+8 places) in the ranking for patient organizations familiar with us.
The 2022 PatientView survey was conducted among 2,207 patient organizations located all around world. Results are reported for 42 pharmaceutical groups in 27 different speciality disease areas.
best uplift in ranking
out of 42 among patient organizations working with pharmaceutical groups
in the number of patient organizations working with Servier in 2022
Last year’s encouraging results have been confirmed, particularly for the following criteria: Patient Information, Ease of working, and R&D engagement.
Our work with patients has been recognized once more, and I’m thrilled. These figures perfectly reflect our desire to integrate the patient voice into the heart of the treatment journey, and at each stage in the medicine life cycle. I’d like to thank patient organizations for this assessment as well as everyone who contributes to achieving these results.Bertrand Renaud, Chief Patient Officer
We recorded another uplift in our ranking in the PatientView survey this year. This significant progress testifies to our desire to work ever more closely with local and international patient organizations on projects based on common interests.Delphine Nicolas, Head of Global Patients Relations for Servier
Servier worked with 29 international patient organizations in 2021/2022.